Axogen (AXGN) EBT (2010 - 2026)

Axogen's EBT history runs 17 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

• On a quarterly basis, EBT rose 24.21% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was -$13.3 million, a 67.28% decrease from a year earlier, with the FY2025 full-year figure at -$67.6 million, down 6.25% from the prior year.
• EBT climbed to -$2.8 million in Q1 2026 per AXGN's latest filing, from -$10.9 million in the prior quarter.
• Across five years, EBT topped out at $474000.0 in Q3 2025 and bottomed at -$12.6 million in Q1 2022.
• The 5-year median for EBT is -$5.3 million (2023), against an average of -$5.3 million.
• Biggest YoY gain for EBT was 124.78% in 2025; the steepest drop was 25852.38% in 2025.
• Year by year, EBT stood at -$4.5 million in 2022, then tumbled by 97.25% to -$9.0 million in 2023, then jumped by 99.53% to -$42000.0 in 2024, then slumped by 25852.38% to -$10.9 million in 2025, then soared by 74.7% to -$2.8 million in 2026.
• Per Business Quant, the three latest AXGN EBT figures stand at -$2.8 million (Q1 2026), -$10.9 million (Q4 2025), and $474000.0 (Q3 2025).